5 Biggest Biotechnology ETFs in 2026
Source: Investing News Network
2026-06-02 16:10:00 ET
The biotech sector has made significant strides in recent years, and the market's volatility can increase the appeal of biotech ETFs.
Even with a good understanding of the system, no one can predict which treatment, device or therapy will give the biggest return, making biotech exchange-traded funds (ETFs) a more secure option than individual biotech stocks.
An ETF is a relatively safe investment route that can minimize losses while offering exposure to multiple companies instead of focusing on the gains and losses of a single biotech stock.
For further details see:
5 Biggest Biotechnology ETFs in 2026
Gilead Sciences Inc.
NASDAQ: GILD
GILD Trading
1.87% G/L:
$131.47 Last:
3,249,390 Volume:
$130.09 Open:
GILD Latest News
June 05, 2026 03:00:00 am
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa
GILD Stock Data
$185,419,569,657
1,228,272,827
0.07%
1237
N/A
Pharmaceuticals
Healthcare
US
Foster City
